Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice
Andreas Muhs(AC Immune (Switzerland)), Claude Nicolau(Tufts University), Detlev Riesner(Heinrich Heine University Düsseldorf), Valérie Giriens(AC Immune (Switzerland)), Maria Pihlgren(World Trade Organization), Nathalie Chuard(AC Immune (Switzerland)), Ruth Greferath(AC Immune (Switzerland)), Carine Meerschman(AC Immune (Switzerland)), Luitgard Nagel‐Steger(Forschungszentrum Jülich), Andrea Pfeifer(AC Immune (Switzerland)), David T. Hickman(AC Immune (Switzerland)), Nadine Kolonko(AC Immune (Switzerland)), Fred Van Leuven(KU Leuven), Masae Sugawara(Institut de Science et d'Ingénierie Supramoléculaires), Ingrid Van der Auwera(University of Illinois Chicago), Burkhard Bechinger(Centre National de la Recherche Scientifique), Roscoe O. Brady(Hadassah Medical Center), Marie-Catherine Weingertner(Institut de Science et d'Ingénierie Supramoléculaires)
Cited by 176
Related Papers
Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
|Journal of Biological Chemistry|1999|668
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
|Journal of Clinical Investigation|2004|622
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency
|Proceedings of the National Academy of Sciences|1999|523